TrialThe Journal of infectious diseases2012

HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.

Katie Mollan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.